View Author
igf-i igf-i bioactivity bioactivity growth effect igf-ii receptor igf-i immunoassays level study h 295 cells treatment ifn -β1a immunoassay igfbp group igf-i kira assay ifn - igf-i levels igf-ir ifnar factor 3 days type i ifns interferon control system sw 13 cells apoptosi protein dna fragmentation figure expression ifn -α2b cancer ifn -␣ caspase medium incubation type i interferons igf system h 295 insulin fragmentation van koetsveld pm tumor insulin-like subject trend serum 1 day model women proliferation activity survival inhibition concentration binding measurement mortality carcinoma table ifn -β1b relationship mortality rate sample metab /well netherland 6 days baseline fland lj sw 13 igf-ii mrna ifnar -2c antitumor activity 0.6 1.0
4 Most Recent Publications
|
Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells
(Article)
Vitale, G. Koetsveld, P.M. van Herder, W.W. de Wansem, K. van der Janssen, J.A.M.J.L. Colao, A. Lombardi, G. Lamberts, S.W.J. Hofland, L.J. |
2009-03-01
|
|
Low Circulating IGF-I Bioactivity in Elderly Men is associated with Increased Mortality
(Article)
Brugts, M.P. Beld, A.W. van den Hofland, L.J. Wansem, K. van der Koetsveld, P.M. van Frystyk, J. Lamberts, S.W.J. Janssen, J.A.M.J.L. |
2008-07-01
|
|
Normal Values of Circulating IGF-I Bioactivity in the Healthy Population: Comparison with five widely used IGF-I immunoassays
(Article)
Brugts, M.P. Ranke, M.B. Hofland, L.J. Wansem, K. van der Weber, K. Frystyk, J. Lamberts, S.W.J. Janssen, J.A.M.J.L. |
2008-07-01
|
|
Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.
(Article)
Koetsveld, P.M. van Vitale, G. Lamberts, S.W.J. Hofland, L.J. Herder, W.W. de Feelders, R.A. Wansem, K. van der Waaijers, M. Eijck, C.H.J. van Speel, E.J. Croze, E. Lely, A.J. van der |
2006-11-01
|
